Amgen to Buy Onyx for $10.4 Billion - New York Times

Top Stories What's going on?

Eventbrite makes it happen Create an event and sell tickets online through Eventbrite. It's simple! Sign up and get started today. From our sponsors

Amgen to Buy Onyx for $10.4 Billion - New York Times Aug 26th 2013, 15:40 New York Times Amgen to Buy Onyx for $10.4 Billion New York Times Onyx's oldest drug is Nexavar, which is approved to treat liver and kidney cancers. Bayer and Onyx PharmaceuticalsOnyx's oldest drug is Nexavar, which is approved to treat liver and kidney cancers. Although Amgen is the world's biggest biotechnology ... Clarification: Amgen-Onyx storyWashington Post US STOCKS-Wall St advances as durables data reduces Fed worryReuters Amgen's Onyx Takeover Is Symptom of Deeper Pharma SicknessBloomberg The Myeloma Beacon -Kansas City Star all 205 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions